ID   FHCC-98
AC   CVCL_L437
DR   BTO; BTO_0006450
DR   Wikidata; Q54834882
RX   PubMed=15133854;
CC   Population: Chinese.
CC   Doubling time: 21.4 hours (PubMed=15133854).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 11
//
RX   PubMed=15133854; DOI=10.3748/wjg.v10.i10.1462; PMCID=PMC4656285;
RA   Lou, Chao-Yang
RA   Feng, Ying-Ming
RA   Qian, Ai-Rong
RA   Li, Yu
RA   Tang, Hao
RA   Shang, Peng
RA   Chen, Zhi-Nan
RT   "Establishment and characterization of human hepatocellular carcinoma
RT   cell line FHCC-98.";
RL   World J. Gastroenterol. 10:1462-1465(2004).
//